PHARMING GRP SP. ADRS Financial Flexibility Index
PHARMING GRP SP. ADRS financial flexibility index. PHARMING GRP SP. ADRS (PHG) has a Financial Flexibility Index of 0.05x as of December 2025. Free cash flow of €10.98 Million (operating CF €10.71 Million minus capex €269.00K) represents 0% of total liabilities (€222.86 Million). See PHG free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of PHARMING GRP SP. ADRS (2021–2025)
Financial flexibility index of PHARMING GRP SP. ADRS from 2021 to 2025. Historical Financial Flexibility Index trend for PHARMING GRP SP. ADRS across 5 annual periods. Check PHG operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
PHARMING GRP SP. ADRS Financial Flexibility Index by Year (2021–2025)
PHARMING GRP SP. ADRS financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for PHARMING GRP SP. ADRS. For the full cash flow conversion analysis, see PHARMING GRP SP. ADRS cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | €55.46 Million | €54.71 Million | €222.86 Million | ▲ +4557.3% |
| 2024 | -0.01x | €-999.00K | €-1.79 Million | €178.92 Million | ▲ +91.4% |
| 2023 | -0.06x | €-15.84 Million | €-17.30 Million | €244.07 Million | ▼ -158.7% |
| 2022 | 0.11x | €24.43 Million | €22.46 Million | €221.16 Million | ▼ -58.6% |
| 2021 | 0.27x | €54.56 Million | €37.84 Million | €204.40 Million | — |